SCHEMBL2901045

SCHEMBL2901045

N#Cc1coc(-c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.44
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
MYC P01106 1/20 0.41
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
TNKS O95271 1/20 0.38
NOTUM Q6P988 2/20 0.38
CYP19A1 P11511 1/20 0.38
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6748070 0.72 MMP3 (0.47) TSHRMYCTNKSNOTUMALDH1A1
SCHEMBL674221 0.72 CHRM2 (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
Biphenyl SCHEMBL27717131 0.71 TSHR (0.48) TSHRMYCNOTUMCYP19A1ALDH1A1
SCHEMBL16050408 0.71 TSHR (0.60) TSHRCYP19A1GABRA1GABRG2GABRB3
SCHEMBL25706168 0.69 CHRM2 (0.51) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL14848480 0.68 RAB9A (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL5307132 0.68 NPC1 (0.43) TSHRTNKSALDH1A1MEN1KMT2A
SCHEMBL27746605 0.68 RAB9A (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL12100428 0.68 ALDH1A1 (0.42) TSHRCHRM2CHRM4CHRM5CHRM1
SCHEMBL15316365 0.68 MAOB (0.44) TSHRCHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022127199-A1 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF 深圳开悦生命科技有限公司 2022-06-23 WO disclosed
EP-2217234-A2 COMBINATIONS OF MEK INHIBITORS WITH MTOR INHIBITORS AstraZeneca AB (SE) 2010-08-18 EP disclosed
WO-2009050506-A2 COMBINATION 059 ASTRAZENECA AB (SE) 2009-04-23 WO disclosed